$CLFD SEC Filings

Filed On	Filing
20 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure This Transition Agreement (the “Agreement”) is made as of October 15, 2026 (the “Effective Date”), by and between Clearfield, Inc. (the “Company”) and Cheryl Beranek (“Executive”).
19 Oct 2026	SCHEDULE 13G/A
06 Aug 2026	FORM 10-Q
05 Aug 2026	8-K: Results of Operations and Financial Condition
28 Jul 2026	8-K: Entry into a Material Definitive Agreement
27 Jul 2026	SCHEDULE 13G
06 Jul 2026	Form 4: Beranek Cheryl, Director Sold 1,778 shares ($71.2K)
02 Jul 2026	Form 4: Herzog Daniel R, Chief Financial Officer Received 752 shares as a grant or award ($18.6K)
02 Jul 2026	Form 4: Khemakhem Anis, Chief Commercial Officer Received 158 shares as a grant or award ($3.92K)
02 Jul 2026	Form 4: Hill John P, Chief Operating Officer Received 459 shares as a grant or award ($11.4K)
02 Jul 2026	Form 4: Beranek Cheryl, Director Received 210 shares as a grant or award ($5.2K)
01 Jul 2026	144
11 Jun 2026	Form 4: Khemakhem Anis, Chief Commercial Officer Sold 1,684 shares ($67.2K)
09 Jun 2026	144
03 Jun 2026	Form 4: Beranek Cheryl, Director Sold 7,500 shares ($352K)
01 Jun 2026	144
28 May 2026	Form 4: Beranek Cheryl, Director Sold 2,500 shares ($125K)
27 May 2026	SD
27 May 2026	144
12 May 2026	Form 4: Beranek Cheryl, Director Sold 5,000 shares ($201K) · Sold 2,500 shares ($113K)

Comments